To evaluate the safety and efficacy of multi component system (TAMBE device) including GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (Aortic Component; AC) under post-marketing use.
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Technical Success
Timeframe: From the initial incision or puncture of the access vessel for the implantation procedure to the closure of the access vessel
Clinical Success
Timeframe: 12 Months
Results related to abdominal branch vessels
Timeframe: 60 Months
Major Adverse Events (MAEs)
Timeframe: 60 Months
Thirty-Day Mortality
Timeframe: 30 Days
Lesion-Related Mortality
Timeframe: 30 Days
Reintervention
Timeframe: 60 Months